Prevention of Thrombosis in Oncohematological Patients

Authors

  • Makhmonov Lutfullo Saydullayevich Chief Physician of Samarkand Regional Multidisciplinary Medical Center, PhD, head of the department hematology, Samarkand State Medical University
  • Khaitov Abdusattor Djumakulovich Head of the Department of Plastic and Reconstructive Microsurgery, Samarkand Regional Multidisciplinary Medical Center
  • Bazarov Bakhrom Boymamatovich Doctor of the Department of Plastic and Reconstructive Microsurgery, Samarkand Regional Multidisciplinary Medical Center
  • Madasheva Anajan Gazkhanovna PhD of the department of hematology, Samarkand State Medical University

DOI:

https://doi.org/10.51699/ijhsms.v2i7.2190

Keywords:

thromboprophylaxis, thromboembolic complications, thrombosis, leukemia, lymphomas, multiple myeloma

Abstract

Cancer patients are at high risk of thrombotic complications, which worsen the outcomes of anticancer treatment and occupy one of the leading places among the causes of death. Thrombosis in a cancer patient increases the risk of death by 30 times, which is associated with the development of fatal thromboembolism and a more aggressive course of the tumor process.

Downloads

Download data is not yet available.

References

Agnelli G., Verso M. Management of venous thromboembolism in patients with cancer. J Thromb Haemost 2011; 1:316–24. DOI: 10.1111/j.1538­7836.2011.04346.

Agnelli G., Verso M. Thromboprophylaxis during chemotherapy in patients with advanced cancer. Thromb Res 2010;125(Suppl 2):S17–20. DOI: 10.1016/S 0049­3848(10)70007­4.

Blom J.W., Doggen C.J.М., Osanto S., Rosendaal F.R. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005;293(6):715–22. DOI: 10.1001/jama.293.6.715.

Goodnough L.T., Saito H., Manni A. et al. Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five­drug chemotherapy regimen. A study of 159 patients. Cancer 1984;54(7):1264–8. DOI: 10.1002/1097­0142(19841001)54: 7<1264::aid­cncr2820540706>3.0.co;2­r.

Konigsbrugge O., Pabinger I., Ay C. Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS). Thromb Res 2014;133(Suppl 2): S39–43. DOI: 10.1016/S0049­ 3848(14)50007­2.

Robin P., Carrier M. Revisiting occult cancer screening in patients with unpro­ voked venous thromboembolism. Thromb Res 2018;164(Suppl 1):S7–11. DOI: 10.1016/j.thromres.2017.12.024.

Ruziboeva, O. N., Abdiev, K. M., Madasheva, A. G., & Mamatkulova, F. K. (2021). Modern Methods Of Treatment Of Hemostasis Disorders In Patients With Rheumatoid Arthritis. Ученый XXI века, 8.

Мадашева, А. Г., & Махмудова, А. Д. (2021). Биохимические показатели у больных гемофилией с мышечными патологиями до и после лечения. Форум молодых ученых, (4 (56)), 233-238.

Gazkhanovna, M. A., Makhmatovich, A. K., & Utkirovich, D. U. (2022). Clinical efficacy of extracorporeal and intravascular hemocorrection methods in psoriasis. ACADEMICIA: An International Multidisciplinary Research Journal, 12(2), 313-318.

Мадашева, А. Г. (2022). Коррекция диффузной алопеции при железодефицитной анемии. Science and Education, 3(12), 231-236.

Махмудова, А. Д., Жураева, Н. Т., & Мадашева, А. Г. (2022). НАСЛЕДСТВЕННЫЙ ДЕФИЦИТ ФАКТОРА СВЕРТЫВАНИЯ КРОВИ Х-БОЛЕЗНЬ СТЮАРТА-ПРАУЭРА. Биология, (4), 137.

Абдиев, К., Махмонов, Л., Мадашева, A., & Маматкулова, Ф. (2021). Business games in teaching hematology. Общество и инновации, 2(6), 208-214.

Downloads

Published

2023-07-07

How to Cite

Saydullayevich, M. L. ., Djumakulovich, K. A. ., Boymamatovich, B. B. ., & Gazkhanovna, M. A. . (2023). Prevention of Thrombosis in Oncohematological Patients. INTERNATIONAL JOURNAL OF HEALTH SYSTEMS AND MEDICAL SCIENCES, 2(7), 17–20. https://doi.org/10.51699/ijhsms.v2i7.2190

Issue

Vol. 2 No. 7 (2023): JULY

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)